EMJ Nephrology
@EMJNephrology
Followers
5K
Following
288
Media
3K
Statuses
10K
EMJ: #1 open access destination for HCPs. Peer-reviewed journals & diverse content hub. Interviews, podcasts, webinars, infographics.
United Kingdom & Europe
Joined December 2013
Join our mailing list for FREE to receive research breakthroughs, news and insights direct to your inbox: https://t.co/6QHTJXkvxV
0
0
0
Your expertise matters. Use the EQOH Score to tell us how our content supports your clinical practice - and help us make it even better. Rate our content today: https://t.co/eyriM77POK
0
0
0
Tired of searching for the latest breakthroughs? What if we could make the most essential knowledge accessible to you - just a tap away? Follow us on Instagram: https://t.co/Dj2BgEEutG
0
0
0
What has over 35 years in nephrology taught one of the field’s leading voices? Uncover more of Patrick Maxwell, Head of the School of Clinical Medicine, @Cambridge_Uni's pioneering research on hypoxia-inducible factors and more in his full interview: https://t.co/HvzvTAZLGa
0
0
0
Sex differences in kidney diseases have so far received limited attention. Uncover the need for more personalised approaches in glomerular conditions on EMJ: https://t.co/a8U0DkGQL1
0
0
0
The latest edition of EMJ Nephrology is out now: https://t.co/RhoPBIjhQh Inside, discover key insights into sarcoidosis, interviews with leading figures in academic nephrology, and all you need to know from @ERAkidney #ERA25. Read the journal today: https://t.co/RhoPBIjhQh
0
0
0
A rare case of lupus vasculitis with severe kidney involvement demonstrates that when formal guidelines fall short, flexible, multidisciplinary care can save lives. Discover how:
emjreviews.com
More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may manifest with...
0
0
1
New trial shows immunoglobulin therapy slows kidney decline in chronic rejection. Discover the latest findings:
emjreviews.com
A new trial finds that intravenous immunoglobulin stabilises kidney function and slows damage in patients with chronic antibody-mediated rejection.
0
0
0
From innovative research in dialysis, kidney transplantation, and more, stay tuned as the team cover the seven key tracks on shaping the future of nephrology @ERAkidney Subscribe to EMJ Nephrology to find out when our full congress coverage is out: https://t.co/gxT5aYUIHt
0
0
0
Hot from ERA Congress 2025: A Spanish team developed a non-invasive, urine-based biomarker model that accurately predicts tubulointerstitial fibrosis in IgA nephropathy. đź”—: https://t.co/wPgZtqajyJ
#medicalresearch #healthcare #ERA #ERA2025
emjreviews.com
A top ERA abstract presents a biomarker-based model that non-invasively estimates kidney fibrosis in patients with IgA nephropathy.
3
0
0
Food insecurity doesn’t raise overall hospitalisation rates in dialysis patients but triples the risk of fluid and electrolyte imbalances, new research shows. Read the full study:
emjreviews.com
A new study finds that food insecurity significantly increases the risk of fluid or electrolyte-related hospitalizations among adults receiving in-center hemodialysis, particularly in younger...
0
0
1
Could current kidney donor screening methods be missing key risks? A new study suggests so, read here:
emjreviews.com
Living kidney donors with discrepancies between body size-adjusted and non-adjusted kidney function measurements face a higher risk of post-donation kidney impairment.
0
0
0
Emerging evidence supports SGLT2 inhibitors for kidney protection in T2DM patients with advanced chronic kidney disease. Read the full findings: https://t.co/vG5FGsxGpl
#MedicalResearch #Nephrology
emjreviews.com
SGLT2 inhibitors reduce the risk of kidney failure in patients with Type 2 diabetes and advanced chronic kidney disease, without increasing infection risks or mortality.
0
0
0
A new study reveals a concerning connection between acute kidney injury, cognitive decline, and probable dementia. Learn more:
emjreviews.com
New research connects mild acute kidney injury (AKI) with increased risks of dementia and cognitive impairment in older adults. Explore the implications for long-term cognitive health and care...
0
0
0
We are searching for engaging and dynamic podcast hosts. You’ll be at the forefront of shaping conversations that inspire, educate and help elevate the quality of care globally amongst HCP's. Apply today or share with your network! https://t.co/T04hRR1P8u
0
0
0
A new combo therapy with daratumumab and tocilizumab shows promise in tackling late antibody-mediated rejection. Read the study:
emjreviews.com
Study finds daratumumab and tocilizumab effective in treating late antibody-mediated rejection after kidney transplant, stabilising renal function and reducing DSAs.
0
0
0
We're on the hunt for dynamic and engaging podcast hosts. You’ll be at the forefront of shaping conversations that inspire, educate and help elevate the quality of care globally amongst HCP's. apply below or share with your network! https://t.co/tz1aacL13h
0
0
0
Could blood test ratios predict mortality in patients requiring hemodialysis? Find out:
emjreviews.com
Neutrophil-to-lymphocyte ratio predicts 1-year mortality in older dialysis patients, highlighting its potential role in personalised care. Read now.
0
0
1
A study has found an increased risk of fractures in female chronic kidney disease patients using alpha blockers for voiding dysfunction. Learn more:
emjreviews.com
Read a new study revealing a higher fracture risk with alpha blockers in female CKD patients treated for voiding dysfunction.
0
0
1
A recent study suggests robot-assisted kidney transplants might be the future, offering similar outcomes with shorter recovery times. Read more:
emjreviews.com
Explore how robot-assisted kidney transplants compare to open surgery for ABO-incompatible patients. Discover insights into safety, effectiveness, and recovery outcomes.
0
0
0